IL125575A0 - 17-beta-cyclopropyl(amino oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20 lyase - Google Patents

17-beta-cyclopropyl(amino oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20 lyase

Info

Publication number
IL125575A0
IL125575A0 IL12557597A IL12557597A IL125575A0 IL 125575 A0 IL125575 A0 IL 125575A0 IL 12557597 A IL12557597 A IL 12557597A IL 12557597 A IL12557597 A IL 12557597A IL 125575 A0 IL125575 A0 IL 125575A0
Authority
IL
Israel
Prior art keywords
alpha
beta
androgen
compounds
lyase
Prior art date
Application number
IL12557597A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of IL125575A0 publication Critical patent/IL125575A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12557597A 1996-02-14 1997-01-09 17-beta-cyclopropyl(amino oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20 lyase IL125575A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60127896A 1996-02-14 1996-02-14
PCT/US1997/000469 WO1997030069A1 (en) 1996-02-14 1997-01-09 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase

Publications (1)

Publication Number Publication Date
IL125575A0 true IL125575A0 (en) 1999-03-12

Family

ID=24406899

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12557597A IL125575A0 (en) 1996-02-14 1997-01-09 17-beta-cyclopropyl(amino oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20 lyase

Country Status (17)

Country Link
EP (1) EP0880540B1 (de)
JP (1) JP2000505444A (de)
KR (1) KR19990082543A (de)
CN (1) CN1211256A (de)
AT (1) ATE219100T1 (de)
AU (1) AU710208B2 (de)
BR (1) BR9708301A (de)
CA (1) CA2244823A1 (de)
DE (1) DE69713285T2 (de)
DK (1) DK0880540T3 (de)
ES (1) ES2178750T3 (de)
HU (1) HUP9900955A3 (de)
IL (1) IL125575A0 (de)
NO (1) NO983724L (de)
NZ (1) NZ327041A (de)
PT (1) PT880540E (de)
WO (1) WO1997030069A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187925B1 (en) 1997-12-23 2001-02-13 Merck & Co., Inc. Intermediates and process for the synthesis of azasteroids
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
WO2002046186A1 (en) * 2000-12-08 2002-06-13 Takeda Chemical Industries, Ltd. Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
EP1622567B1 (de) 2003-05-07 2013-07-24 Merck Sharp & Dohme Corp. Androgen-rezeptor-modulatoren und verfahren zu ihrer verwendung
US20100261689A1 (en) * 2007-10-29 2010-10-14 Masuo Yamaoka Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
BRPI0920681A2 (pt) * 2008-10-28 2015-12-29 Biomarin Pharm Inc inibidores de decahidro-1h-indenoquinolinona e decahidro-3h-ciclopentafenantridinona de cyp17
WO2011088160A2 (en) * 2010-01-15 2011-07-21 Biomarin Pharmaceutical Inc. Novel cyp17 inhibitors
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic
CN109438549B (zh) * 2018-12-13 2022-01-04 湖北葛店人福药业有限责任公司 一种制备N-叔丁基-3-氧代-4-氮杂-5α-雄甾-17β-甲酰胺的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264427A (en) * 1992-01-29 1993-11-23 Research Corporation Technologies, Inc. 20-substituted pregnene derivatives and their use as androgen synthesis inhibitors
KR950701527A (ko) * 1992-05-21 1995-04-28 라브리 페르낭 테스토스테론 5α 환원효소 활성 저해제(INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY)
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase

Also Published As

Publication number Publication date
NO983724L (no) 1998-10-13
WO1997030069A1 (en) 1997-08-21
DK0880540T3 (da) 2002-10-07
DE69713285D1 (en) 2002-07-18
KR19990082543A (ko) 1999-11-25
ES2178750T3 (es) 2003-01-01
CN1211256A (zh) 1999-03-17
CA2244823A1 (en) 1997-08-21
NO983724D0 (no) 1998-08-13
PT880540E (pt) 2002-10-31
AU710208B2 (en) 1999-09-16
JP2000505444A (ja) 2000-05-09
EP0880540A1 (de) 1998-12-02
AU1576797A (en) 1997-09-02
NZ327041A (en) 1999-11-29
ATE219100T1 (de) 2002-06-15
HUP9900955A2 (hu) 1999-07-28
BR9708301A (pt) 1999-08-03
EP0880540B1 (de) 2002-06-12
HUP9900955A3 (en) 2000-06-28
DE69713285T2 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
AU6045398A (en) Androgen synthesis inhibitors
KR910004651A (ko) 5α-환원효소 억제제로서의 17β-아실-4-아자-5α-안드로스트-1-엔-3-온
RU94046057A (ru) Ингибиторы активности тестостерон 5 альфа -редуктазы, фармкомпозиция, способ подавления активности, тестостерон 5 альфа -редуктазы
DK1084569T3 (da) Androgener i kombination med gestagener til udligning af et testosteronunderskud med beskyttelse af prostata
BR9708301A (pt) Esteróides de 17-beta-ciclopropil (amino/óxi) 4-aza como inibidores ativos de 5-alfa-redutase e liase de c17-20 de testosterona
GEP20125397B (en) Helix 12 directed non-steroidal antiandrogens
CY1107862T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν παραγωγα οιστερολης για χρηση στη θεραπεια του καρκινου
MY157898A (en) Helix 12 directed steroidal pharmaceutical products
DK1494993T3 (da) Hidtil ukendte Curcumin-analoger og anvendelser deraf
WO2001025397A3 (en) Compositions and methods for tumor-targeted delivery of effector molecules
IL111357A0 (en) 16-substituted-4-aza-androstanes, their preparation and pharmaceutical compositions containing them
TR199900556T2 (xx) Prostat hipertrofisini ve prostat kanserini tedavi etmek i�in vas�ta.
AR021757A1 (es) Metodo para inhibir la conversion de 4-androstan-3,17-diona en testosterona o de 3alfa-androstan-3,17-diona en dihidrotestosterona, inhibir la actividadde la 3alfa-hidroxiesteroide deshidrogenasa de tipo 3 humana, para determinar la eficacia de un inhibidor putativo de la conversion de 4-androsten-3
AU7950000A (en) Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase
DE69823222D1 (de) Dihydronaphthalinderivate und verfahren zur herstellung derselben
MXPA03002495A (es) Proceso para preparacion de compuestos de n-(fenil sustituido)-3-alquil, aril- y heteroarilsulfonil-2-hidroxi-2-alquil- y haloalquilpropanamida.
ATE178795T1 (de) 7-substituierte-4-aza-steroid-derivate als 5- alpha-reductase-hemmer
AU674971B2 (en) 4-amino-17beta -(cyclopropyloxy)androst-4-en-3-one, 4-amino-17beta -(cyclopropylamino)androst-4-en-3-one and related compounds as C-17-20 lyase and 5alpha-reductase inhibitors
IL126328A (en) 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND USE THEREOF
Kurup et al. Comparative QSAR analysis of 5α-reductase inhibitors
Morzycki et al. Synthesis of 4, 17-diazasteroid inhibitors of human 5α-reductase
ATE198274T1 (de) 17 beta-aryl-4-aza-steroidderivate
Nnane et al. Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo
WO2001058919A3 (en) Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
EP0862556A4 (de) 17-alkyl-7-substituierte-4-aza-steroidderivate